These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22882641)

  • 1. Fatty liver: cause or consequence.
    Hitman GA
    Diabet Med; 2012 Sep; 29(9):1097. PubMed ID: 22882641
    [No Abstract]   [Full Text] [Related]  

  • 2. Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management.
    Byrne CD
    Diabet Med; 2012 Sep; 29(9):1098-107. PubMed ID: 22672330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin.
    Polyzos SA; Kountouras J; Zavos C; Stergiopoulos C
    Med Hypotheses; 2010 Jun; 74(6):1089-90. PubMed ID: 20080361
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes.
    Grønbaek H; Thomsen KL; Rungby J; Schmitz O; Vilstrup H
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):705-11. PubMed ID: 19072347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetes and the liver].
    Herzig S; Roden M
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1204-6. PubMed ID: 23720171
    [No Abstract]   [Full Text] [Related]  

  • 6. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.
    Leung TM; Nieto N
    J Hepatol; 2013 Feb; 58(2):395-8. PubMed ID: 22940046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
    Saruç M; Yüceyar H; Ayhan S; Türkel N; Tuzcuoglu I; Can M
    Hepatogastroenterology; 2003; 50(51):771-4. PubMed ID: 12828082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The cutting-edge of medicine; clinical and molecular pathology of type 2 diabetic liver].
    Takamura T; Misu H; Kaneko S
    Nihon Naika Gakkai Zasshi; 2011 Jun; 100(6):1670-6. PubMed ID: 21770296
    [No Abstract]   [Full Text] [Related]  

  • 9. Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway.
    Li J; Chi Y; Wang C; Wu J; Yang H; Zhang D; Zhu Y; Wang N; Yang J; Guan Y
    Hepatology; 2011 Jun; 53(6):1906-16. PubMed ID: 21412813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children.
    Bedogni G; Gastaldelli A; Manco M; De Col A; Agosti F; Tiribelli C; Sartorio A
    Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):120-6. PubMed ID: 20880682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
    Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstructive sleep apnea and dyslipidemia: importance of the liver axis.
    Mirrakhimov AE; Mirrakhimov EM
    Sleep Breath; 2013 May; 17(2):443-4. PubMed ID: 23070526
    [No Abstract]   [Full Text] [Related]  

  • 13. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.
    Bozzetto L; Prinster A; Mancini M; Giacco R; De Natale C; Salvatore M; Riccardi G; Rivellese AA; Annuzzi G
    Eur J Clin Invest; 2011 Jan; 41(1):39-44. PubMed ID: 20825466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and the liver: developmental perspectives.
    Hoppin AG
    Semin Liver Dis; 2004 Nov; 24(4):381-7. PubMed ID: 15605306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.
    Franko A; Neschen S; Rozman J; Rathkolb B; Aichler M; Feuchtinger A; Brachthäuser L; Neff F; Kovarova M; Wolf E; Fuchs H; Häring HU; Peter A; Hrabě de Angelis M
    Mol Metab; 2017 Mar; 6(3):256-266. PubMed ID: 28271032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance.
    Kim SK; Choi YJ; Huh BW; Park SW; Lee EJ; Cho YW; Huh KB
    J Clin Endocrinol Metab; 2014 May; 99(5):1879-84. PubMed ID: 24512497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside.
    Gariani K; Philippe J; Jornayvaz FR
    Diabetes Metab; 2013 Feb; 39(1):16-26. PubMed ID: 23266468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity, hypertension, and insulin resistance.
    Bloomgarden ZT
    Diabetes Care; 2002 Nov; 25(11):2088-97. PubMed ID: 12401761
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
    Farrell GC; Larter CZ
    Hepatology; 2006 Feb; 43(2 Suppl 1):S99-S112. PubMed ID: 16447287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction to the Mini-Symposium on non-alcoholic fatty liver disease.
    Persico M
    Dig Liver Dis; 2010 May; 42(5):309. PubMed ID: 20304711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.